PCI Pharma Services ("PCI" or the "Company"), a world-leading global contract development and manufacturing organization ...

The new investment will support both organic and inorganic expansion, including growth in sterile fill-finish injectables, ...

PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

A Philadelphia-based pharmaceutical services company has just received a massive investment from two major private equity firms, reportedly catapulting its valuation to $10 billion.

More recently, PCI acquired a 100% stake in Ajinomoto’s fill-finish contracting arm Ajinomoto Althea. The deal, for which ...

PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global supply chain solutions provider, today announced the acquisition of B ...

Private equity firm Partners Group on Wednesday will announce an agreement to acquire PCI Pharma Services, a Philadelphia-based provider of outsourced services to the global pharmaceutical market ...

The auction of Frazier Healthcare Partners-backed PCI Pharma Services, which potentially valued the pharmaceutical outsourcing company at more than $1 billion, has attracted the interest of ...

PCI Pharma Services began life as a drug packaging company before diversifying its business into the production of tablets, capsules, and semisolid and liquid oral preparations.

PCI Pharma Services, a Philadelphia contract drug manufacturer, is investing $50 million into a new manufacturing facility in Rockford that's expected to create about 250 jobs.